Cargando…
Complement System in Cutaneous Squamous Cell Carcinoma
Epidermal keratinocyte-derived cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer with high mortality rates in the advanced stage. Chronic inflammation is a recognized risk factor for cSCC progression and the complement system, as a part of innate immunity, belongs to...
Autores principales: | Riihilä, Pilvi, Nissinen, Liisa, Knuutila, Jaakko, Rahmati Nezhad, Pegah, Viiklepp, Kristina, Kähäri, Veli-Matti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678994/ https://www.ncbi.nlm.nih.gov/pubmed/31331124 http://dx.doi.org/10.3390/ijms20143550 |
Ejemplares similares
-
Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma
por: Rahmati Nezhad, Pegah, et al.
Publicado: (2022) -
Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study
por: KNUUTILA, Jaakko S., et al.
Publicado: (2020) -
Super Enhancer-Regulated LINC00094 (SERLOC) Upregulates the Expression of MMP-1 and MMP-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma
por: Piipponen, Minna, et al.
Publicado: (2022) -
Identification of metastatic primary cutaneous squamous cell carcinoma utilizing artificial intelligence analysis of whole slide images
por: Knuutila, Jaakko S., et al.
Publicado: (2022) -
The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma
por: Piipponen, Minna, et al.
Publicado: (2021)